Oncolytics Biotech Inc. (ONC.TO)
| Previous Close | 1.6200 |
| Open | 1.6300 |
| Bid | 1.6000 x 0 |
| Ask | 1.6200 x 0 |
| Day's Range | 1.5900 - 1.6300 |
| 52 Week Range | 1.2000 - 4.4900 |
| Volume | |
| Avg. Volume | 70,585 |
| Market Cap | 122.18M |
| Beta (5Y Monthly) | 1.45 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.4100 |
| Earnings Date | May 09, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 6.67 |
- Baystreet
Stocks in play: Oncolytics Biotech Inc
Today announced that Dr. Matt Coffey, President and Chief Executive Officer, will participate in a fireside ...
PR NewswireOncolytics Biotech® to Participate in a Fireside Chat at the 2024 RBC Capital Markets Global Healthcare Conference
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that Dr. Matt Coffey, President and Chief Executive Officer, will participate in a fireside chat at the 2024 RBC Capital Markets Global Healthcare Conference, which is taking place May 14-15, 2024 at the InterContinental New York Barclay in New York, NY. Additional details on the fireside chat can be found below.
CNW GroupOncolytics Biotech® to Host Conference Call to Discuss First Quarter Financial Results and Recent Operational Highlights
Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced that it will host a conference call and webcast on Thursday, May 9, 2024, at 4:30 p.m. ET to discuss a corporate update and financial results for the first quarter 2024.
